| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 2, 2024 | TWST Twist Bioscience Corp | Cho Dennis70 | See Remarks | Sell | 129 | $32.74 | $4,222.94 | -0.2% | +48.6% | +16.1% | |
| Apr 1, 2024 | VCYT Veracyte, Inc. | Eastham Karin67 | Director | Sell | 10,000 | $21.65 | $216,528.00 | -23.2% | -1.4% | +36.6% | |
| Apr 1, 2024 | EXAS Exact Sciences Corp | Condella Sarah75 | EVP, Human Resources | Sell | 2,000 | $70.00 | $140,000.00 | -2.7% | -39.7% | -38.3% | |
| Mar 28, 2024 | NTRA Natera, Inc. | Fesko John | President, Chief Bus. Officer | Sell | 464 | $90.42 | $41,952.93 | -0.4% | +21.8% | +57.4% | |
| Mar 28, 2024 | EXAS Exact Sciences Corp | Condella Sarah75 | EVP, Human Resources | Sell | 2,000 | $70.00 | $140,000.00 | -2.6% | -36.1% | -36.8% | |
| Mar 28, 2024 | NTRA Natera, Inc. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 707 | $90.42 | $63,923.97 | -0.4% | +21.8% | +57.4% | |
| Mar 28, 2024 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 914 | $90.42 | $82,640.04 | -1.3% | +21.8% | +57.4% | |
| Mar 28, 2024 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 1,447 | $90.16 | $130,456.41 | -0.2% | +21.8% | +57.4% | |
| Mar 28, 2024 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 743 | $90.42 | $67,178.94 | -0.4% | +21.8% | +57.4% | |
| Mar 28, 2024 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 53,572 | $89.09 | $4,772,752.27 | -15.4% | +21.8% | +57.4% | |
| Mar 25, 2024 | A Agilent Technologies, Inc. | Binns Philip | Senior Vice President | Sell | 2,827 | $147.54 | $417,095.58 | -22.0% | -7.2% | -17.2% | |
| Mar 21, 2024 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 6,336 | $20.28 | $128,514.14 | -1.1% | -0.1% | -2.7% | |
| Mar 20, 2024 | TWST Twist Bioscience Corp | Banyai William81 | See Remark | Sell | 442 | $33.52 | $14,814.07 | -0.1% | +42.8% | +18.8% | |
| Mar 20, 2024 | TWST Twist Bioscience Corp | Green Paula69 | SVP Of Human Resources | Sell | 200 | $33.52 | $6,703.20 | -0.2% | +42.8% | +18.8% | |
| Mar 20, 2024 | TWST Twist Bioscience Corp | Cho Dennis70 | See Remarks | Sell | 230 | $33.52 | $7,708.68 | -0.3% | +42.8% | +18.8% | |
| Mar 20, 2024 | TWST Twist Bioscience Corp | Leproust Emily M.77 | Chief Executive Officer | Sell | 1,128 | $33.52 | $37,806.05 | -0.2% | +42.8% | +18.8% | |
| Mar 18, 2024 | GH Guardant Health, Inc. | Kalia Kumud61 | Chief Information Officer | Buy | 2,187 | $17.82 | $38,962.72 | +20.8% | +74.8% | +151.3% | |
| Mar 18, 2024 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 500,000 | $0.87 | $437,100.00 | +0.2% | +44.4% | +106.8% | |
| Mar 18, 2024 | WGS Genedx Holdings Corp. | Stueland Katherine | Chief Executive Officer | Sell | 8,559 | $10.59 | $90,661.21 | -11.4% | +187.2% | +839.9% | |
| Mar 18, 2024 | WGS Genedx Holdings Corp. | Feeley Kevin46 | Chief Financial Officer | Sell | 3,253 | $10.59 | $34,454.80 | -10.1% | +187.2% | +839.9% | |
| Mar 18, 2024 | WGS Genedx Holdings Corp. | Saad Kareem61 | Chief Transformation Officer | Sell | 2,008 | $10.59 | $21,269.34 | -6.4% | +187.2% | +839.9% | |
| Mar 15, 2024 | MEDP Medpace Holdings, Inc. | Burwig Susan E64 | Exec. VP, Operations | Sell | 102 | $403.00 | $41,106.00 | -0.7% | -0.7% | -18.1% | |
| Mar 15, 2024 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 83,223 | $88.96 | $7,403,533.72 | -9.6% | +23.8% | +65.6% | |
| Mar 14, 2024 | TWST Twist Bioscience Corp | Cho Dennis70 | See Remarks | Sell | 93 | $34.60 | $3,217.80 | -0.1% | +51.7% | +15.6% | |
| Mar 14, 2024 | MEDP Medpace Holdings, Inc. | Keating Ashley M.67 | Director | Sell | 250 | $409.87 | $102,467.50 | -50.0% | -0.2% | -19.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.